perspective
The Montreal model clinical team recommends reducing the use of benzodiazepines and related sedatives (BZDRs) for patients with treatment-resistant depression, citing evidence of tolerance, potential harms, and questionable long-term efficacy.

Authors

Sources

Referenced by nodes (3)